GREGORY G GERMINO, M.D.
Osteopathic Medicine at Wolfe St, Baltimore, MD
License number
Maryland D44177
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
600 N Wolfe St, Baltimore, MD 21287
Phone
(410) 955-0670
Personal information
See more information about GREGORY G GERMINO at radaris.comName
Address
Phone
7310 Pomander Ln, Chevy Chase, MD 20815
7310 Pomander Ln, Chevy Chase, MD 20815
Professional information
Dr. Gregory G Germino, Bethesda MD - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
31 Ctr Dr SUITE 31, Bethesda 20892
9000 Rockville Pike, Bethesda 20892
(301) 496-5877 (Phone), (301) 402-2125 (Fax)
601 N 7Th St, Baltimore 21287
600 N Wolfe St, Baltimore 21287
(410) 955-0670 (Phone)
JOHNS HOPKINS HOSPITAL
600 N Wolfe St, Baltimore 21287
(410) 955-5080 (Phone), (410) 955-1464 (Fax)
9000 Rockville Pike, Bethesda 20892
(301) 496-5877 (Phone), (301) 402-2125 (Fax)
601 N 7Th St, Baltimore 21287
600 N Wolfe St, Baltimore 21287
(410) 955-0670 (Phone)
JOHNS HOPKINS HOSPITAL
600 N Wolfe St, Baltimore 21287
(410) 955-5080 (Phone), (410) 955-1464 (Fax)
Certifications:
Internal Medicine, 1986
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
31 Ctr Dr SUITE 31, Bethesda 20892
600 N Wolfe St, Baltimore 21287
9000 Rockville Pike, Bethesda 20892
601 N 7Th St, Baltimore 21287
JOHNS HOPKINS HOSPITAL
600 N Wolfe St, Baltimore 21287
The Johns Hopkins Hospital
1800 Orleans St, Baltimore 21287
600 N Wolfe St, Baltimore 21287
9000 Rockville Pike, Bethesda 20892
601 N 7Th St, Baltimore 21287
JOHNS HOPKINS HOSPITAL
600 N Wolfe St, Baltimore 21287
The Johns Hopkins Hospital
1800 Orleans St, Baltimore 21287
Education:
Medical School
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1983
Yale New Haven Hospital
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1983
Yale New Haven Hospital
Gregory George Germino, Baltimore MD
Specialties:
Internal Medicine, Nephrology
Work:
Johns Hopkins University
600 N Wolfe St, Baltimore, MD 21287
600 N Wolfe St, Baltimore, MD 21287
Education:
University of Chicago (1983)
Polycystic Kidney Disease Gene And Protein
US Patent:
6071717, Jun 6, 2000
Filed:
Jun 4, 1996
Appl. No.:
8/658136
Inventors:
Katherine Klinger - Sudbury MA
Timothy Burn - Northborough MA
Timothy Connors - Hopkinton MA
William Dackowski - Hopkinton MA
Gregory Germino - Baltimore MD
Feng Qian - Baltimore MD
Gregory Landes - Northborough MA
Timothy Burn - Northborough MA
Timothy Connors - Hopkinton MA
William Dackowski - Hopkinton MA
Gregory Germino - Baltimore MD
Feng Qian - Baltimore MD
Gregory Landes - Northborough MA
Assignee:
Genzyme Corporation - Framingham MA
Johns Hopkins University - Baltimore MD
Johns Hopkins University - Baltimore MD
International Classification:
C07H 2104, C07K 14435, C12N 1563, C12P 2102
US Classification:
435 691
Abstract:
The present invention involves isolated nucleic acid encoding human PKD1, and sequences derived therefrom. The invention also encompasses vectors comprising these nucleic acids, host cells transformed with the vectors, and methods for producing PKD1 protein or fragments thereof. In another aspect, the invention involves isolated oligonucleotides that hybridize only to the authentic expressed PKD1 gene, and not to PKD1 homologues. In yet another aspect, the invention involves isolated mutant PKD1 genes, and their cDNA cognates. Further provided are isolated oligonucleotides that discriminate between normal and mutant versions of the PKD1 gene. Methods and compositions for treating APKD or disease conditions having the characteristics of APKD are also provided.
Polycystic Kidney Disease Gene
US Patent:
5654170, Aug 5, 1997
Filed:
Oct 12, 1994
Appl. No.:
8/323443
Inventors:
Katherine W. Klinger - Sudbury MA
Gregory M. Landes - Northborough MA
Timothy C. Burn - Northborough MA
Timothy D. Connors - Hopkinton MA
William Dackowski - Hopkinton MA
Gregory Germino - Baltimore MD
Feng Qian - Baltimore MD
Gregory M. Landes - Northborough MA
Timothy C. Burn - Northborough MA
Timothy D. Connors - Hopkinton MA
William Dackowski - Hopkinton MA
Gregory Germino - Baltimore MD
Feng Qian - Baltimore MD
Assignee:
Johns Hopkins University - Baltimore MD
Genzyme Corporation - Cambridge MA
Genzyme Corporation - Cambridge MA
International Classification:
C12P 2102, C12N 1563, C07H 2104
US Classification:
435 691
Abstract:
The present invention involves isolated nucleic acid encoding human PKD1, and sequences derived therefrom. The invention also encompasses vectors comprising these nucleic acids, host cells transformed with the vectors, and methods for producing PKD1 protein or fragments thereof. In another aspect, the invention involves isolated oligonucleotides that hybridize only to the authentic expressed PKD1 gene, and not to PKD1 homologues. In yet another aspect, the invention involves isolated mutant PKD1 genes, and their cDNA cognates. Further provided are isolated oligonucleotides that discriminate between normal and mutant versions of the PKD1 gene. Methods and compositions for treating APKD or disease conditions having the characteristics of APKD are also provided.
Polycystic Kidney Disease Gene
US Patent:
6867288, Mar 15, 2005
Filed:
Jun 2, 1995
Appl. No.:
08/460215
Inventors:
Katherine W. Klinger - Sudbury MA, US
Gregory M. Landes - Northborough MA, US
Timothy C. Burn - Northborough MA, US
Timothy D. Connors - Hopkinton MA, US
William Dackowski - Hopkinton MA, US
Gregory Germino - Baltimore MD, US
Feng Qian - Baltimore MD, US
Gregory M. Landes - Northborough MA, US
Timothy C. Burn - Northborough MA, US
Timothy D. Connors - Hopkinton MA, US
William Dackowski - Hopkinton MA, US
Gregory Germino - Baltimore MD, US
Feng Qian - Baltimore MD, US
Assignee:
Genzyme Corporation - Cambridge MA
Johns Hopkins University - Baltimore MD
Johns Hopkins University - Baltimore MD
International Classification:
C07H021/02, C12N015/63
US Classification:
536 231, 4353201
Abstract:
The present invention provides methods and compositions for treating cyst formation in PKD1-associated epithelial cells. Such methods encompass administering an isolated human PKD1 gene, or fragments of the gene, under conditions that result in expression of therapeutically effective amounts of all, or part of, the PKD1 protein. The invention also encompasses compositions for treating cyst formation associated with APKD.